Clinical Trials Browser

Interventional × Lymphoma × veltuzumab × Clear all

NCT00285428 2021-08-17

Study of hA20 (Humanized Anti-CD20) in Patients With CD20+ Non-Hodgkin's Lymphoma

Phase 1/2 Completed

Lymphoma, Lymphoma, Non-Hodgkin